Drug Shortage Report for MOVISSE
Report ID | 84070 |
Drug Identification Number | 02410303 |
Brand name | MOVISSE |
Common or Proper name | NORETHINDRONE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | NORETHINDRONE |
Strength(s) | 0.35MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 28BL |
ATC code | G03AC |
ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2019-05-14 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | 2019-08-30 |
Shortage status | Resolved |
Updated date | 2019-08-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2019-08-31 | English | Compare |
v6 | 2019-08-30 | French | Compare |
v5 | 2019-08-30 | English | Compare |
v4 | 2019-08-30 | English | Compare |
v3 | 2019-05-15 | English | Compare |
v2 | 2019-05-14 | French | Compare |
v1 | 2019-05-14 | English | Compare |
Showing 1 to 7 of 7